Well, Well, Well. Suddenly we are no longer slagging the company and now we think we are on the up. Nothing to do with suddenly being a holder is it?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%